BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| MAGE-4 (143-151) | MAGE-4 (143-151) is a bioactive peptide of MAGE-4. The Melanoma-Associated Antigen A4 (MAGE-A4) protein is a target for cancer therapy. It may play a role in embryonal development and tumor transformation or aspects of tumor progression. Synonyms: Melanoma-Associated Antigen 4 (143-151); MAGEA4 (143-151). |  |
| MAGE-4 (156-163) | MAGE-4 (156-163) is a bioactive peptide of MAGE-4. The Melanoma-Associated Antigen A4 (MAGE-A4) protein is a target for cancer therapy. It may play a role in embryonal development and tumor transformation or aspects of tumor progression. Synonyms: Melanoma-Associated Antigen 4 (156-163); MAGEA4 (156-163). | |
| MAGE-4 (169-177) | MAGE-4 (169-177) is a bioactive peptide of MAGE-4. The Melanoma-Associated Antigen A4 (MAGE-A4) protein is a target for cancer therapy. It may play a role in embryonal development and tumor transformation or aspects of tumor progression. Synonyms: Melanoma-Associated Antigen 4 (169-177); MAGEA4 (169-177). | |
| MAGE-4 (230-239) | MAGE-4 (230-239) is a bioactive peptide of MAGE-4. The Melanoma-Associated Antigen A4 (MAGE-A4) protein is a target for cancer therapy. It may play a role in embryonal development and tumor transformation or aspects of tumor progression. Synonyms: Melanoma-Associated Antigen 4 (230-239); MAGEA4 (230-239). | |
| MAGE-5 (5-12) | MAGE-5 (5-12) is a bioactive peptide of MAGE-5. It may play a role in embryonal development and tumor transformation or aspects of tumor progression. Synonyms: Melanoma-Associated Antigen 5 (5-12); Cancer/Testis Antigen 1.5 (5-12). | |
| MAGE-6 (121-134) | MAGE-6 (121-134) is a peptide corresponding to residues 121-134 of MAGE-6. MAGE-6 functions in tumor transformation or aspects of tumor progression. It promotes cell viability in melanoma cell lines in vitro. Synonyms: Melanoma-Associated Antigen 6 (121-134); Cancer/Testis Antigen 1.6 (121-134). | |
| MAGE-6 (168-176) | MAGE-6 (168-176) is a peptide corresponding to residues 168-176 of MAGE-6. MAGE-6 functions in tumor transformation or aspects of tumor progression. It promotes cell viability in melanoma cell lines in vitro. Synonyms: Melanoma-Associated Antigen 6 (168-176); Cancer/Testis Antigen 1.6 (168-176). | |
| MAGE-6 (290-298) | MAGE-6 (290-298) is a peptide corresponding to residues 290-298 of MAGE-6. MAGE-6 functions in tumor transformation or aspects of tumor progression. It promotes cell viability in melanoma cell lines in vitro. Synonyms: Melanoma-Associated Antigen 6 (290-298); Cancer/Testis Antigen 1.6 (290-298). | |
| MAGE-6 (293-301) | MAGE-6 (293-301) is a peptide corresponding to residues 293-301 of MAGE-6. MAGE-6 functions in tumor transformation or aspects of tumor progression. It promotes cell viability in melanoma cell lines in vitro. Synonyms: Melanoma-Associated Antigen 6 (293-301); Cancer/Testis Antigen 1.6 (293-301). | |
| MAGE-9 (223-231) | MAGE-9 (223-231) is a bioactive peptide of MAGE-9. MAGE-A9 is a particular member in the context of the MAGE-A gene family and was defined as presenting prognostic relevance in certain type of human cancer. Synonyms: Melanoma-Associated Antigen 9 (223-231); Cancer/Testis Antigen Family 1, Member 9 (223-231). | |
| MAGE-A10 | MAGE-A10 is a member of the MAGE-A family of cancer/testis tumor-associated antigens (C/T TAAs). MAGE-A10 could be used as a potential target for tumor immunotherapy. Synonyms: Val-Ile-Trp-Glu-Ala-Leu-Asn-Met-Met-Gly-Leu-Tyr-Asp-Gly-Met-Glu-His-Leu-Ile-Tyr-Gly-Glu-Pro-Arg-Lys-Leu-Leu-Thr-Gln-Asp. Molecular formula: C159H247N39O46S3. Mole weight: 3537.32. | |
| MAGE-A3 | MAGE-A3 is a member of the MAGE-A family of cancer/testis tumor-associated antigens (C/T TAAs). MAGE-A3 could be used as a potential target for tumor immunotherapy. Synonyms: Ser-Arg-Lys-Val-Ala-Glu-Leu-Val-His-Phe-Leu-Leu-Leu-Lys-Tyr-Arg-Ala-Arg-Glu-Pro-Val-Thr-Lys-Ala-Glu-Met-Leu-Gly-Ser-Val-Val. Molecular formula: C161H271N45O42S. Mole weight: 3451.43. | |
| MAGE-A3 (195-203) | MAGE-A3 (195-203) is a human leukocyte antigen (HLA)-A24 molecules epitope encoded by melanoma antigen gene (MAGE). Synonyms: H-Ile-Met-Pro-Lys-Ala-Gly-Leu-Leu-Ile-OH; L-isoleucyl-L-methionyl-L-prolyl-L-lysyl-L-alanyl-glycyl-L-leucyl-L-leucyl-L-isoleucine. Grade: ≥95%. CAS No. 171066-85-6. Molecular formula: C45H82N10O10S. Mole weight: 955.26. | |
| Mammaglobin-A (23-31) | Mammaglobin-A (23-31) is a truncated fragment of Mammaglobin-A. Mammaglobin-A is an attractive target for immune-based therapy for patients with breast cancer because of its exclusive expression in breast cancer. | |
| Mammaglobin-A precursor (2-10) | A peptide fragment of Mammaglobin-A precursor. Mammaglobin-A is an attractive target for immune-based therapy for patients with breast cancer because of its exclusive expression in breast cancer. | |
| Mammaglobin-A precursor (32-40) | A peptide fragment of Mammaglobin-A precursor. Mammaglobin-A is an attractive target for immune-based therapy for patients with breast cancer because of its exclusive expression in breast cancer. | |
| Mammaglobin-A precursor (4-12) | A peptide fragment of Mammaglobin-A precursor. Mammaglobin-A is an attractive target for immune-based therapy for patients with breast cancer because of its exclusive expression in breast cancer. | |
| Mammaglobin-A precursor (66-74) | A peptide fragment of Mammaglobin-A precursor. Mammaglobin-A is an attractive target for immune-based therapy for patients with breast cancer because of its exclusive expression in breast cancer. | |
| Mammaglobin-A precursor (83-92) | A peptide fragment of Mammaglobin-A precursor. Mammaglobin-A is an attractive target for immune-based therapy for patients with breast cancer because of its exclusive expression in breast cancer. | |
| Manduca Sexta Moricin | Manduca Sexta Moricin exhibited potent antimicrobial activities against a broad spectrum of Gram-positive and Gram-negative bacteria with a minimum inhibitory concentration of 1.4 μm. | |
| MAP | Multiple Antigenic peptides (MAPs) are artificially branched peptides with lysine residues as the scaffold core, supporting the formation ≤8 branches with varying or the same peptide sequences. MAPs have been used to produce antibodies for immunological research. MAPs have a high molar ratio of peptide antigen to core molecule and does not require carrier protein to elicit antibody response. Synonyms: H-Lys-Leu-Ala-Leu-Lys-Leu-Ala-Leu-His-Ala-Leu-Lys-Ala-Ala-Leu-Lys-Leu-Ala-Lys-Leu-Ala-Leu-Lys-Leu-Ala-Leu-Lys-Ala-Leu-Lys-Ala-Ala-Leu-Lys-Leu-Ala-OH. Grade: >98%. Molecular formula: C180H331N47O37. Mole weight: 3745.92. | |
| MAP (KLAL) | MAP (KLAL) is an amphipathic α-helical cell-penetrating peptide (CPP). CPP can bind macromolecules and be used as a drug delivery vehicle. Synonyms: H-Lys-Leu-Ala-Leu-Lys-Leu-Ala-Leu-Lys-Ala-Leu-Lys-Ala-Ala-Leu-Lys-Leu-Ala-OH; L-lysyl-L-leucyl-L-alanyl-L-leucyl-L-lysyl-L-leucyl-L-alanyl-L-leucyl-L-lysyl-L-alanyl-L-leucyl-L-lysyl-L-alanyl-L-alanyl-L-leucyl-L-lysyl-L-leucyl-L-alanine. Grade: ≥95%. Molecular formula: C90H169N23O19. Mole weight: 1877.48. | |
| MAPK/MAK/MRK overlapping kinase (11-20) | MAPK/MAK/MRK overlapping kinase (11-20) is a 10-aa peptide. MAPK/MAK/MRK overlapping kinase is able to phosphorylate several exogenous substrates and to undergo autophosphorylation. | |
| MAPK/MAK/MRK overlapping kinase (32-40) | MAPK/MAK/MRK overlapping kinase (32-40) is a 9-aa peptide. MAPK/MAK/MRK overlapping kinase is able to phosphorylate several exogenous substrates and to undergo autophosphorylation. | |
| MAPK/MAK/MRK overlapping kinase (352-360) | MAPK/MAK/MRK overlapping kinase (352-360) is a 9-aa peptide. MAPK/MAK/MRK overlapping kinase is able to phosphorylate several exogenous substrates and to undergo autophosphorylation. | |
| MARCKS Peptide (151-175), Phosphorylated | MARCKS Peptide (151-175), Phosphorylated is a phosphorylated peptide corresponding to the basic effector domain of myristoylated alanine-rich protein kinase C substrate protein (MARCKS). Phosphorylation of MARCKS Peptide (151-175) reverses its inhibition of phosphatidylinositol 4,5-diphosphate (PIP2) catalyzed hydrolysis by phospholipase C (PLC). Synonyms: Lys-Lys-Lys-Lys-Lys-Arg-Phe-pSer-Phe-Lys-Lys-pSer-Phe-Lys-Leu-Ser-Gly-Phe-pSer-Phe-Lys-Lys-Asn-Lys-Lys. Grade: ≥95%. Molecular formula: C147H246N41O40P3. Mole weight: 3320.69. | |
| MARK Substrate | MARK Substrate is a MARK substrate peptide. Synonyms: L-Lysine, L-asparaginyl-L-valyl-L-lysyl-L-seryl-L-lysyl-L-isoleucylglycyl-L-seryl-L-threonyl-L-α-glutamyl-L-asparaginyl-L-leucyl-; Asn-Val-Lys-Ser-Lys-Ile-Gly-Ser-Thr-Glu-Asn-Leu-Lys. Grade: ≥95%. CAS No. 847991-34-8. Molecular formula: C60H108N18O21. Mole weight: 1417.61. | |
| MART-1 (100-111) | MART-1 (100-111) is a peptide derived from MART-1, a protein antigen that is found on the surface of melanocytes. It is beneficial to research in the treatment of melanoma. Synonyms: Protein melan-A (100-111); melanoma antigen recognized by T cells 1 (100-111). | |
| MART-1 (100-114) | MART-1(100-114) is a peptide derived from MART-1, a protein antigen that is found on the surface of melanocytes. It is beneficial to research in the treatment of melanoma. Synonyms: Protein melan-A (100-114); melanoma antigen recognized by T cells 1 (100-114). | |
| MART-1 (100-116) | MART-1(100-116) is a peptide derived from MART-1, a protein antigen that is found on the surface of melanocytes. It is beneficial to research in the treatment of melanoma. Synonyms: Protein melan-A (100-116); melanoma antigen recognized by T cells 1 (100-116). | |
| MART-1 (1-20) | MART-1 (1-20) is a peptide derived from MART-1, a protein antigen that is found on the surface of melanocytes. It is beneficial to research in the treatment of melanoma. Synonyms: Protein melan-A (1-20); melanoma antigen recognized by T cells 1 (1-20). | |
| MART-1 (24-33(34)) | MART-1 (24-33(34)) is a peptide derived from MART-1, a protein antigen that is found on the surface of melanocytes. It is beneficial to research in the treatment of melanoma. Synonyms: Protein melan-A (24-33(34)); melanoma antigen recognized by T cells 1 (24-33(34)). | |
| MART-1 (27-35) (human) | MART-1 represents amino acids 27-35 of MART-1 protein, which is a melanoma antigen recognized by T cells. Synonyms: Melanoma-associated antigen peptide. Grade: ≥98% by HPLC. CAS No. 156251-11-5. Molecular formula: C37H67N9O11. Mole weight: 813.98. | |
| MART-1 (32-40) | The Melan-A(aa32-40) peptide is a human leukocyte antigen (HLA)-A2-restricted T-cell epitope within the Melan-A/MART-1 tumor antigen expressed on malignant melanoma cells. | |
| MART-1 (51-61) | MART-1 (51-61) is a peptide derived from MART-1, a protein antigen that is found on the surface of melanocytes. It is beneficial to research in the treatment of melanoma. Synonyms: Protein melan-A (51-61); melanoma antigen recognized by T cells 1 (51-61). | |
| MART-1 (51-73) | MART-1 (51-73) is a peptide derived from MART-1, a protein antigen that is found on the surface of melanocytes. It is beneficial to research in the treatment of melanoma. Synonyms: Protein melan-A (51-73); melanoma antigen recognized by T cells 1 (51-73). | |
| MART-1 (91-110) | MART-1 (91-110) is a peptide derived from MART-1, a protein antigen that is found on the surface of melanocytes. It is beneficial to research in the treatment of melanoma. Synonyms: Protein melan-A (91-110); melanoma antigen recognized by T cells 1 (91-110). | |
| MART-1 (97-116) | MART-1(97-116) is a peptide derived from MART-1, a protein antigen that is found on the surface of melanocytes. It is beneficial to research in the treatment of melanoma. Synonyms: Protein melan-A (97-116); melanoma antigen recognized by T cells 1 (97-116). | |
| MART 1 peptide (1-10) | The Melan-A(aa1-10) peptide is a human leukocyte antigen (HLA)-A2-restricted T-cell epitope within the Melan-A/MART-1 tumor antigen expressed on malignant melanoma cells. | |
| Mast Cell Degranulating Peptide HR-2 | Mast Cell Degranulating Peptide HR-2 is a 14-membered linear peptide isolated from the venom of the giant hornet Vespa orientalis that degranulates mast cells and thus initiates histamine release. Synonyms: H-Phe-Leu-Pro-Leu-Ile-Leu-Gly-Lys-Leu-Val-Lys-Gly-Leu-Leu-NH2; L-phenylalanyl-L-leucyl-L-prolyl-L-leucyl-L-isoleucyl-L-leucyl-glycyl-L-lysyl-L-leucyl-L-valyl-L-lysyl-glycyl-L-leucyl-L-leucinamide. Grade: ≥95%. CAS No. 80388-04-1. Molecular formula: C77H135N17O14. Mole weight: 1523.00. | |
| Mast Cell Degranulating Peptide HR-2 acetate | Mast Cell Degranulating Peptide HR-2 is a 14-membered linear peptide isolated from the venom of the giant hornet Vespa orientalis that degranulates mast cells and thus initiates histamine release. Molecular formula: C79H139N17O16. Mole weight: 1583.08. | |
| Mastoparan-A | Mastoparan-A exhibits antimicrobial activity against both Gram-positive and -negative bacteria as well as haemolytic activity on chicken, human and sheep erythrocytes. It has a role as an antibacterial agent. Synonyms: MP-A. Molecular formula: C79H138N20O16. Mole weight: 1624.1. | |
| Mastoparan B | Mastoparan B (MPB) is a venom peptide isolated from Vespa basalis (black-bellied hornet), one of the dangerous vespine wasps found in Taiwan. Mastopran-B is the major active component of the venom of the hornet Vespa basalis and causes degranulation of mast cells as well as hemolysis on chicken, human and sheep erythrocytes. It also exhibits antimicrobial activity against both Gram-positive and -negative bacteria. Synonyms: MP-B; Mast cell degranulating peptide (vespa basalis). Grade: >96% by HPLC. CAS No. 137354-65-5. Molecular formula: C78H138N20O16. Mole weight: 1612.05. | |
| Mastoparan-like peptide 12a | Mastoparan-like peptide 12a is a mast cell degranulating peptide with little hemolytic activity. It shows antimicrobial activity against the Gram-negative bacteria E.coli, the Gram-positive bacteria S.aureus and the fungus C.albicans. | |
| Mastoparan-like peptide 12b | Mastoparan-like peptide 12b is a mast cell degranulating peptide with little hemolytic activity. It shows antimicrobial activity against the Gram-negative bacteria E.coli, the Gram-positive bacteria S.aureus and the fungus C.albicans. | |
| Mastoparan-like peptide 12c precursor | Mastoparan-like peptide 12c precursor shows mast cell degranulation and antimicrobial activities against the Gram-negative bacteria E.coli, the Gram-positive bacteria S.aureus and the fungus C.albicans). | |
| Mastoparan-like peptide 12d | Mastoparan-like peptide 12d shows mast cell degranulation and antimicrobial activities against the Gram-negative bacteria E.coli, the Gram-positive bacteria S.aureus and the fungus C.albicans. | |
| Mastoparan M | Mastoparan M exhibits antimicrobial activity against both Gram-positive and -negative bacteria as well as haemolytic activity on chicken, human and sheep erythrocytes. It has a role as an antibacterial agent. Synonyms: L-Leucinamide, L-isoleucyl-L-asparaginyl-L-leucyl-L-lysyl-L-alanyl-L-isoleucyl-L-alanyl-L-alanyl-L-leucyl-L-alanyl-L-lysyl-L-lysyl-L-leucyl-; H-Ile-Asn-Leu-Lys-Ala-Ile-Ala-Ala-Leu-Ala-Lys-Lys-Leu-Leu-NH2; L-isoleucyl-L-asparagyl-L-leucyl-L-lysyl-L-alanyl-L-isoleucyl-L-alanyl-L-alanyl-L-leucyl-L-alanyl-L-lysyl-L-lysyl-L-leucyl-L-leucinamide; Mastoparan 12c (Vespa magnifica venom). Grade: ≥95%. CAS No. 79396-77-3. Molecular formula: C70H131N19O15. Mole weight: 1478.90. | |
| Mastoparan-T | Mastoparan-T is a chemotactic peptide for polymorphonucleated leukocytes (PMNL), but causing no hemolysis to erythrocytes and no mast cell degranulation activity at physiological concentrations. Mastoparan-T is also a potent antimicrobial peptide against Gram-positive and Gram-negative bacteria. | |
| Mastoparan-V1 | Mastoparan-V1 is a chemotactic peptide for polymorphonucleated leukocytes (PMNL), but causing no hemolysis to erythrocytes and no mast cell degranulation activity at physiological concentrations. Mastoparan-V1 is also a potent antimicrobial peptide against Gram-positive and Gram-negative bacteria. Synonyms: MP-V1. Grade: >96% by HPLC. Molecular formula: C81H140N22O19S. Mole weight: 1758.17. | |
| Mastoparan-V2 | Mastoparan-V2 is a chemotactic peptide for polymorphonucleated leukocytes (PMNL), but causing no hemolysis to erythrocytes and no mast cell degranulation activity at physiological concentrations. Mastoparan-V2 is also a potent antimicrobial peptide against Gram-positive and Gram-negative bacteria. Synonyms: MP-V2. | |
| MASTP_PROSY Mastoparan | MASTP_PROSY Mastoparan has antibacterial activity. MASTP_PROSY Mastoparan was found in Protonectarina sylveirae [Brazilian wasp]. Grade: >96% by HPLC. Molecular formula: C75H128N20O17. Mole weight: 1581.94. | |
| Matrilysin (96-107) | Matrilysin (MAT) is a member of the matrix metalloproteinase (MMP) family which is believed to degrade components of the extracellular matrix (ECM) during processes of tissue remodeling. Synonyms: MMP7 (96-107). | |
| Matrix protein 1 (229-237) | Matrix protein 1 (229-237) is a peptide derived from M1, a matrix protein of the influenza virus. And it is associated with Human respiratory syncytial virus and lung carcinoma. Synonyms: M1 (229-237). | |
| Matrix protein 1 (27-35) | Matrix protein 1 (27-35) is a peptide derived from M1, a matrix protein of the influenza virus. And it is associated with Influenza A virus and lung carcinoma. Synonyms: M1 (27-35). | |
| Matrix Protein M1 (58-66) (Influenza A virus) | It is the epitope of influenza A virus matrix protein. Synonyms: Matrix protein 1 (58-66); FLUM1 A2 peptide (58-66); CEF1, Influenza Matrix Protein M1 58-66; Gly-Ile-Leu-Gly-Phe-Val-Phe-Thr-Leu; glycyl-L-isoleucyl-L-leucyl-glycyl-L-phenylalanyl-L-valyl-L-phenylalanyl-L-threonyl-L-leucine. Grade: ≥95%. CAS No. 141368-69-6. Molecular formula: C49H75N9O11. Mole weight: 966.17. | |
| Maurocalcine | Maurocalcine is a highly potent cell-penetrating peptide isolated from the Tunisian scorpion Maurus palmatus. It is an activator of Ca2+ release channel and a Ryanodine receptors agonist. It is a 33-mer basic peptide cross-linked by three disulfide bridges. Synonyms: MCa. Grade: >97%. | |
| Maximin 1 | Maximin 1 has antibacterial, antifungal, antiviral activity. The source of Maximin 1 is Chinese red belly toad, Bombina maxima, Yunnan, China, Asia. It is active against E. coli ATCC25922, S. aureus ATCC2592, B. pyocyaneus CMCCB10104, B. megatherium, B. dysenterium, K. pneumoniae, and C. albicans ATCC2002 (MIC 3-20 μM). It also has spermicidal effect. Grade: >95% by HPLC. Molecular formula: C120H209N33O35. Mole weight: 2674.14. | |
| Maximin-11 | Maximin-11 is from Bombina maxima and it shows antimicrobial activity against bacteria and against the fungus C.albicans. It has little hemolytic activity. Synonyms: Maximin-11 antimicrobial peptide. | |
| Maximin 15 | Maximin 15 has antibacterial and antifungal activities. The source of Maximin 15 is Bombina maxima [Giant fire-bellied toad]. | |
| Maximin 2 | Maximin 2 has antibacterial and antifungal activities. The source of Maximin 2 is Bombina maxima [Giant fire-bellied toad]. | |
| Maximin 28 | Maximin 28 has antibacterial and antifungal activities. The source of Maximin 28 is Bombina maxima [Giant fire-bellied toad]. | |
| Maximin 3 | Maximin 3 shows antibacterial activity against both Gram-positive and Gram-negative bacteria. It also shows antimicrobial activity against the fungus C.albicans, but not against A.flavus nor P.uticale. It has little hemolytic activity. Maximin 3 possesses a significant cytotoxicity against tumor cell lines and possesses a significant anti-HIV activity. It also shows high spermicidal activity. | |
| Maximin 31 | Maximin 31 has antibacterial and antifungal activities. The source of Maximin 31 is Bombina maxima [Giant fire-bellied toad]. | |
| Maximin 32 | Maximin 32 has antibacterial and antifungal activities. The source of Maximin 32 is Bombina maxima [Giant fire-bellied toad]. | |
| Maximin 39 | Maximin 39 has antibacterial and antifungal activities. The source of Maximin 39 is Bombina maxima [Giant fire-bellied toad]. | |
| Maximin 4 | Maximin 4 has antibacterial, antifungal and antiviral activities. The source of Maximin 4 is Chinese red belly toad, Bombina maxima, Yunnan, China, Asia. It is active against E. coli ATCC25922, S. aureus ATCC2592, B. pyocyaneus CMCCB10104, B. megatherium, B. dysenterium, K. pneumoniae, and C. albicans ATCC2002 (MIC 1.5-15 μM). Synonyms: H-Gly-Ile-Gly-Gly-Val-Leu-Leu-Ser-Ala-Gly-Lys-Ala-Ala-Leu-Lys-Gly-Leu-Ala-Lys-Val-Leu-Ala-Glu-Lys-Tyr-Ala-Asn-OH. Grade: >96% by HPLC. Molecular formula: C119H206N32O33. Mole weight: 2613.09. | |
| Maximin 41 | Maximin 41 has antibacterial and antifungal activities. The source of Maximin 41 is Bombina maxima [Giant fire-bellied toad]. | |
| Maximin 42 | Maximin 42 has antibacterial and antifungal activities. The source of Maximin 42 is Bombina maxima [Giant fire-bellied toad]. Grade: >95% by HPLC. | |
| Maximin 45 | Maximin 45 has antibacterial and antifungal activities. The source of Maximin 45 is Bombina maxima [Giant fire-bellied toad]. | |
Our database is helping our users find suppliers everyday.
